Natura &Co price target raised to $9 from $8 at JPMorgan

JPMorgan analyst Joseph Giordano raised the firm’s price target on Natura &Co to $9 from $8 and keeps an Overweight rating on the shares. The sale of Aesop is a "transformational move" for Natura &Co, the analyst tells investors in a research note. The deal should bring the company to a net cash position, supporting a free cash flow yield in the high-single-digit range from a cash burn trajectory given the lower debt burden, and also potentially position it "back as a solid dividend play," contends the firm.